What's new? See the latest updates
The Modern Compounding Pharmacy
The partners you need for the pharmacy experience you should expect.
For medical clinics, telehealth companies, and independent practices.
Technology
Better Technology for Better Operations
Your compounding pharmacy should do more—and we do.
Never pick up the phone again
Get proactive alerts about any stuck prescriptions and fix it through our dashboards or API.
Know where every prescription is
Track every order that goes through our pharmacy, from the moment we receive the e-prescription until it's delivered to your patient's door.
Count on reconcilable invoicing, accurate to the cent
Receive automated, transparent invoices that are easy to search and cross-reference with multiple locations, providers, or EINs.
Discover how Blend's tech works for you
PHYSICAL
PHYSICAL
Increase retention
Delight your customers with small-batch, branded packaging that reinforces a 1:1 relationship. Fast turnaround times mean treatment starts right away, while extended expiration dates support better compliance—ultimately increasing lifetime value.
Improve outcomes
Our bases are crafted from scratch. Our formulas are nuanced and personalized. When your patient gets better results, everyone wins.
Decrease costs
Let our software do all of the coordination and billing for you. Cut pharmacy operations time to a fraction of what it is today.
expertise
Meet the people behind your prescriptions
We've scaled telemed companies, built compounding pharmacies, and launched software used by millions.
Dan DiStefano, PharmD
Co-founder, Chief Pharmacist
Dan has led pharmacy operations for trusted names in telehealth, compounding, and clinical care. He's built compounding pharmacies from conception to scale and served as VP of Pharmacy Operations at 9amHealth, Director of Pharmacy at Hims & Hers (NYSE: HIMS), and VP at Curexa. Dan brings deep expertise in customized formulations, fulfillment, and clinical quality.
Ben Holber
Co-founder
Ben is the co-founder and former CEO of Apostrophe, a teledermatology and compounding pharmacy brand acquired by Hims & Hers (NYSE: HIMS) for $193m. Ben understands the operational and regulatory complexities of building a telehealth brand—and how the right pharmacy partner can unlock growth.
Ryan Hambley
Co-founder
Ryan co-founded Apostrophe and led product, marketing, and operations through its growth and acquisition by Hims & Hers (NYSE: HIMS). Ryan brings a deep understanding of how modern clinics and telehealth brands can differentiate through thoughtful packaging, clear communication, and seamless pharmacy integration.
John Davi
Co-founder, CTO
John is a technology leader with a track record of building scalable platforms for healthcare and consumer brands. He's held leadership roles at Regis (NYSE: RGS), Mindbody (acquired for $2B), and AI innovator Diffbot. John focuses on building pharmacy infrastructure that makes fulfillment faster, clearer, and easier to manage.
© 2025 Blend Innovations, Inc. All rights reserved.
Licensing
Licensing
